Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, et al
In the UK, these treatments are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA)
With tirzepatide, the active ingredient in Zepbound, people lost an average of 15% to 21% of their body weight over 72 weeks
Graphical Abstract Similar content being viewed by others Introduction Cardiovascular disease (CVD) represents the primary cause of mortality in patients with type 2 diabetes mellitus (T2DM) [1]
However, providers should also be clear about the need to carefully monitor asthma symptoms and be prepared to make adjustments to the treatment plan as needed